Biora Therapeutics Provides Outlook for 2024
January 16, 2024 08:00 ET
|
Biora Therapeutics, Inc.
Biora anticipates 2024 catalysts, including clinical study results for NaviCap™ platform and progress on pharma partnerships for BioJet™ platform.
Biora Therapeutics Progresses Research Collaboration for the BioJet™ Systemic Oral Delivery Platform
January 02, 2024 08:00 ET
|
Biora Therapeutics, Inc.
Biora's BioJet™ drug delivery platform exceeded performance targets for delivery of collaborator AstraZeneca’s molecule in preclinical study.
Biora Therapeutics Announces New Research Collaboration for the BioJet™ Systemic Oral Delivery Platform
December 11, 2023 08:00 ET
|
Biora Therapeutics, Inc.
Pharma collaborator’s proprietary molecules will be tested with the BioJet platform in animal models.